Area of research
Oncology · Cancer Research
Research interest
Research interests include Biology, Cell biology, RHOA, Medicine, Cancer research, and Immune checkpoint.
Targeting IGF1R Overcomes Armored and Cold Tumor Microenvironment and Boosts Immune Checkpoint Blockade in Triple‐Negative Breast Cancer
Polycystin‐1 Mutant Alters Mechanotransduction in Response to Collagen and Extracellular Matrix Stiffness via Daam1‐Dependent Microfilament Remodeling
Formin protein DAAM1 positively regulates PD-L1 expression via mediating the JAK1/STAT1 axis in pancreatic cancer
Conserved immuno‐collagenic subtypes predict response to immune checkpoint blockade
Angiotensin receptor blocker attacks armored and cold tumors and boosts immune checkpoint blockade
RBM12 drives PD-L1-mediated immune evasion in hepatocellular carcinoma by increasing JAK1 mRNA translation
Protocol to identify novel immunotherapy biomarkers based on transcriptomic data in human cancers
Angiotensin-converting enzyme 2 identifies immuno-hot tumors suggesting angiotensin-(1–7) as a sensitizer for chemotherapy and immunotherapy in breast cancer
SARS-CoV-2 spike protein dictates syncytium-mediated lymphocyte elimination
Retardant effect of dihydroartemisinin on ulcerative colitis in a JAK2/STAT3-dependent manner
Subtype-Based Analysis of Cell-in-Cell Structures in Esophageal Squamous Cell Carcinoma
EGF-stimulated activation of Rab35 regulates RUSC2–GIT2 complex formation to stabilize GIT2 during directional lung cancer cell migration
The R3-MYB Gene GhCPC Negatively Regulates Cotton Fiber Elongation
EGF-reduced<i>Wnt5a</i>transcription induces epithelial-mesenchymal transition via Arf6-ERK signaling in gastric cancer cells
Rab35 is required for Wnt5a/Dvl2-induced Rac1 activation and cell migration in MCF-7 breast cancer cells
GEP100 regulates epidermal growth factor-induced MDA-MB-231 breast cancer cell invasion through the activation of Arf6/ERK/uPAR signaling pathway
PI3K/Akt-dependent phosphorylation of GSK3β and activation of RhoA regulate Wnt5a-induced gastric cancer cell migration